These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 25663643)

  • 1. Erratum to: Biological performance of a polycaprolactone-based scaffold plus recombinant human morphogenetic protein-2 (rhBMP-2) in an ovine thoracic interbody fusion model.
    Yong MR; Saifzadeh S; Woodruff M; Askin GN; Labrom RD; Hutmacher DW; Adam CJ
    Eur Spine J; 2015 Apr; 24(4):871. PubMed ID: 25663643
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of an injectable silk fibroin enhanced calcium phosphate cement loaded with human recombinant bone morphogenetic protein-2 in ovine lumbar interbody fusion.
    Gu Y; Chen L; Yang HL; Luo ZP; Tang TS
    J Biomed Mater Res A; 2011 May; 97(2):177-85. PubMed ID: 21381189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating lumbar fusions by combining rhBMP-2 with allograft bone: a prospective analysis of interbody fusion rates and clinical outcomes.
    Slosar PJ; Josey R; Reynolds J
    Spine J; 2007; 7(3):301-7. PubMed ID: 17482113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness and safety of recombinant human bone morphogenetic protein-2 versus local bone graft in primary lumbar interbody fusions.
    Adams CL; Ogden K; Robertson IK; Broadhurst S; Edis D
    Spine (Phila Pa 1976); 2014 Jan; 39(2):164-71. PubMed ID: 24153173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ISSLS prize winner: positron emission tomography and magnetic resonance imaging for monitoring interbody fusion with equine bone protein extract, recombinant human bone morphogenetic protein-2, and autograft.
    Foldager C; Bendtsen M; Zou X; Zou L; Olsen AK; Munk OL; Stødkilde-Jørgensen H; Bünger C
    Spine (Phila Pa 1976); 2008 Dec; 33(25):2683-90. PubMed ID: 19002076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective analysis of L5-S1 axial lumbar interbody fusion (AxiaLIF): a comparison with and without the use of recombinant human bone morphogenetic protein-2.
    Gerszten PC; Tobler WD; Nasca RJ
    Spine J; 2011 Nov; 11(11):1027-32. PubMed ID: 22122835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polycaprolactone scaffold and reduced rhBMP-7 dose for the regeneration of critical-sized defects in sheep tibiae.
    Cipitria A; Reichert JC; Epari DR; Saifzadeh S; Berner A; Schell H; Mehta M; Schuetz MA; Duda GN; Hutmacher DW
    Biomaterials; 2013 Dec; 34(38):9960-8. PubMed ID: 24075478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nerve injury and recovery after lateral lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a cohort-controlled study.
    Lykissas MG; Aichmair A; Sama AA; Hughes AP; Lebl DR; Cammisa FP; Girardi FP
    Spine J; 2014 Feb; 14(2):217-24. PubMed ID: 24269858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications in the use of rhBMP-2 in PEEK cages for interbody spinal fusions.
    Vaidya R; Sethi A; Bartol S; Jacobson M; Coe C; Craig JG
    J Spinal Disord Tech; 2008 Dec; 21(8):557-62. PubMed ID: 19057248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic-RGD is as effective as rhBMP-2 in anterior interbody fusion of the sheep cervical spine.
    Scholz M; Schleicher P; Sewing A; Gelinsky M; Kandziora F
    Spine (Phila Pa 1976); 2013 Jan; 38(2):E59-65. PubMed ID: 23124266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone morphogenetic protein-binding peptide reduces the inflammatory response to recombinant human bone morphogenetic protein-2 and recombinant human bone morphogenetic protein-7 in a rodent model of soft-tissue inflammation.
    Lee KB; Murray SS; Taghavi CE; Song KJ; Brochmann EJ; Johnson JS; Keorochana G; Liao JC; Wang JC
    Spine J; 2011 Jun; 11(6):568-76. PubMed ID: 21729805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications with recombinant human bone morphogenetic protein-2 in posterolateral spine fusion associated with a dural tear.
    Glassman SD; Gum JL; Crawford CH; Shields CB; Carreon LY
    Spine J; 2011 Jun; 11(6):522-6. PubMed ID: 20598649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study of laparoscopical lumbar interbody fusion with polyporus composite phosphate calcium and rhBMP-2 compounds in sheep].
    Zhu ZH; Cao P; Liang Y; Gong YC; Zheng T; Zhang XK; Wu WJ
    Zhonghua Yi Xue Za Zhi; 2010 Jun; 90(21):1503-6. PubMed ID: 20973226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats.
    Miyazaki M; Morishita Y; He W; Hu M; Sintuu C; Hymanson HJ; Falakassa J; Tsumura H; Wang JC
    Spine J; 2009; 9(1):22-30. PubMed ID: 18805060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative complications of recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge versus iliac crest bone graft for posterior cervical arthrodesis.
    Crawford CH; Carreon LY; McGinnis MD; Campbell MJ; Glassman SD
    Spine (Phila Pa 1976); 2009 Jun; 34(13):1390-4. PubMed ID: 19440166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological performance of a polycaprolactone-based scaffold used as fusion cage device in a large animal model of spinal reconstructive surgery.
    Abbah SA; Lam CX; Hutmacher DW; Goh JC; Wong HK
    Biomaterials; 2009 Oct; 30(28):5086-93. PubMed ID: 19540586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does recombinant human bone morphogenetic protein-2 use in adult spinal deformity increase complications and are complications associated with location of rhBMP-2 use? A prospective, multicenter study of 279 consecutive patients.
    Bess S; Line BG; Lafage V; Schwab F; Shaffrey CI; Hart RA; Boachie-Adjei O; Akbarnia BA; Ames CP; Burton DC; Deverin V; Fu KM; Gupta M; Hostin R; Kebaish K; Klineberg E; Mundis G; O'Brien M; Shelokov A; Smith JS;
    Spine (Phila Pa 1976); 2014 Feb; 39(3):233-42. PubMed ID: 24477081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simple carrier matrix modifications can enhance delivery of recombinant human bone morphogenetic protein-2 for posterolateral spine fusion.
    Akamaru T; Suh D; Boden SD; Kim HS; Minamide A; Louis-Ugbo J
    Spine (Phila Pa 1976); 2003 Mar; 28(5):429-34. PubMed ID: 12616152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vivo biological effects of intradiscal recombinant human bone morphogenetic protein-2 on the injured intervertebral disc: an animal experiment.
    Huang KY; Yan JJ; Hsieh CC; Chang MS; Lin RM
    Spine (Phila Pa 1976); 2007 May; 32(11):1174-80. PubMed ID: 17495773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical sequelae after rhBMP-2 use in a minimally invasive transforaminal lumbar interbody fusion.
    Singh K; Nandyala SV; Marquez-Lara A; Cha TD; Khan SN; Fineberg SJ; Pelton MA
    Spine J; 2013 Sep; 13(9):1118-25. PubMed ID: 24029138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.